tiprankstipranks
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market

Trevi Therapeutics (TRVI) Technical Analysis

270 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Trevi Therapeutics Inc’s (TRVI) Moving Averages Convergence Divergence (MACD) indicator is 0.33, suggesting Trevi Therapeutics Inc is a Sell.
Trevi Therapeutics Inc’s (TRVI) 20-Day exponential moving average is 2.03, while Trevi Therapeutics Inc’s (TRVI) share price is $2.49, making it a Buy.
Trevi Therapeutics Inc’s (TRVI) 50-Day exponential moving average is 1.72, while Trevi Therapeutics Inc’s (TRVI) share price is $2.49, making it a Buy.

Trevi Therapeutics (TRVI) Pivot Points

Feb 24, 2024, 04:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.92
2.20
2.40
2.68
2.88
3.16
3.36
Fibonacci
2.20
2.38
2.50
2.68
2.86
2.98
3.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Trevi Therapeutics (TRVI) Moving Averages

Feb 24, 2024, 04:43 AM
Period
Simple
Exponential
MA5
2.64Sell
2.52Sell
MA10
2.30Buy
2.32Buy
MA20
1.88Buy
2.03Buy
MA50
1.56Buy
1.72Buy
MA100
1.56Buy
1.69Buy
MA200
1.95Buy
1.92Buy
Trevi Therapeutics Inc’s (TRVI) 10-Day exponential moving average is 2.32, while Trevi Therapeutics Inc’s (TRVI) share price is $2.49, making it a Buy.
Trevi Therapeutics Inc’s (TRVI) 100-Day exponential moving average is 1.69, while Trevi Therapeutics Inc’s (TRVI) share price is $2.49, making it a Buy.
Trevi Therapeutics Inc’s (TRVI) stock price is $2.49 and Trevi Therapeutics Inc’s (TRVI) 50-day simple moving average is 1.56, creating a Buy signal.
Trevi Therapeutics Inc’s (TRVI) stock price is $2.49 and Trevi Therapeutics Inc’s (TRVI) 100-day simple moving average is 1.56, creating a Buy signal.
Trevi Therapeutics Inc’s (TRVI) stock price is $2.49 and Trevi Therapeutics Inc’s (TRVI) 200-day simple moving average is 1.95, creating a Buy signal.

Trevi Therapeutics (TRVI) Technical Indicators

Feb 24, 2024, 04:43 AM
Name
Value
Implied Action
RSI (14)
73.61
Sell
STOCH (9,6)
61.98
Neutral
STOCHRSI (14)
65.53
Neutral
MACD (12,26)
0.33
Sell
ADX (14)
41.10
Neutral
Williams %R
-39.78
Buy
CCI (14)
94.28
Neutral
ATR (14)
0.23
-
Ultimate Oscillator
56.62
Neutral
ROC
79.14
Buy
Trevi Therapeutics Inc’s (TRVI) Relative Strength Index (RSI) is 73.61, creating a Sell signal.
Trevi Therapeutics Inc’s (TRVI) Trend Strength Indicator (ADX) is 41.10, creating a Neutral signal.
Trevi Therapeutics Inc’s (TRVI) Commodity Channel Index (CCI) is 94.28, creating a Neutral signal.
Trevi Therapeutics Inc’s (TRVI) Price Rate of Change (ROC) is 79.14, creating a Buy signal.

FAQ

Is TRVI a Buy, Hold, or Sell?
Based on TRVI’s technical indicators, TRVI is a Buy.
    What is TRVI’s RSI (14)?
    TRVI’s RSI (14) is 73.61, which suggests TRVI is a Sell.
      What is TRVI’s MACD?
      TRVI’s MACD is 0.33, which suggests TRVI is a Sell.
        What is TRVI’s 5-day moving average?
        TRVI’s 5-day moving average is 2.64, which suggests TRVI is a Sell.
          What is TRVI’s 20-day moving average?
          TRVI 20-day moving average is 1.88, which suggests TRVI is a Buy.
            What is TRVI’s 50-day moving average?
            TRVI’s 50-day moving average is 1.56, which suggests TRVI is a Buy.
              What is TRVI’s 200-day moving average?
              TRVI’s 200-day moving average is 1.95, which suggests TRVI is a Buy.
                What is TRVI’s Williams % R (14)?
                TRVI’s Williams % R (14) is -39.78, which suggests TRVI is a Buy.
                  What is TRVI’s CCI (14)?
                  TRVI’s CCI (14) is 94.28, which suggests TRVI is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis